Characterization of the conversion between CD133⁺ and CD133^- cells in colon cancer SW620 cell line

References

• Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 2011; 108:7950 - 5; http://dx.doi.org/10.1073/pnas.1102454108; PMID: 21498687
   PubMed Web of Science ®Google Scholar
• Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146:633 - 44; http://dx.doi.org/10.1016/j.cell.2011.07.026; PMID: 21854987
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821 - 8; PMID: 14522905
   PubMed Web of Science ®Google Scholar
• Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313 - 23; http://dx.doi.org/10.1016/j.stem.2007.06.002; PMID: 18371365
   PubMed Web of Science ®Google Scholar
• Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15:504 - 14; http://dx.doi.org/10.1038/sj.cdd.4402283; PMID: 18049477
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106 - 10; http://dx.doi.org/10.1038/nature05372; PMID: 17122772
   PubMed Web of Science ®Google Scholar
• Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132:2542 - 56; http://dx.doi.org/10.1053/j.gastro.2007.04.025; PMID: 17570225
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445:111 - 5; http://dx.doi.org/10.1038/nature05384; PMID: 17122771
   PubMed Web of Science ®Google Scholar
• Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009; 457:603 - 7; http://dx.doi.org/10.1038/nature07589; PMID: 19092805
   PubMed Web of Science ®Google Scholar
• Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118:2111 - 20; PMID: 18497886
   PubMed Web of Science ®Google Scholar
• Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 2008; 15:638 - 48; http://dx.doi.org/10.1245/s10434-007-9605-3; PMID: 17932721
   PubMed Web of Science ®Google Scholar
• Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, et al. CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 2008; 15:2927 - 33; http://dx.doi.org/10.1245/s10434-008-0074-0; PMID: 18663533
   PubMed Web of Science ®Google Scholar
• Miao ZH, Player A, Shankavaram U, Wang YH, Zimonjic DB, Lorenzi PL, et al. Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses. Cancer Res 2007; 67:8752 - 61; http://dx.doi.org/10.1158/0008-5472.CAN-06-4554; PMID: 17875716
   PubMed Web of Science ®Google Scholar
• Golovnina K, Blinov A, Akhmametyeva EM, Omelyanchuk LV, Chang LS. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene. BMC Evol Biol 2005; 5:69; http://dx.doi.org/10.1186/1471-2148-5-69; PMID: 16324214
   PubMed Web of Science ®Google Scholar
• Mahloogi H, González-Guerrico AM, Lopez De Cicco R, Bassi DE, Goodrow T, Braunewell KH, et al. Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res 2003; 63:4997 - 5004; PMID: 12941826
   PubMed Web of Science ®Google Scholar
• Smith DP, Rayter SI, Niederlander C, Spicer J, Jones CM, Ashworth A. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum Mol Genet 2001; 10:2869 - 77; http://dx.doi.org/10.1093/hmg/10.25.2869; PMID: 11741830
   PubMed Web of Science ®Google Scholar
• Tonissen KF. Targeting the human thioredoxin system by diverse strategies to treat cancer and other pathologies. Recent Pat DNA Gene Seq 2007; 1:164 - 75; http://dx.doi.org/10.2174/187221507782360227; PMID: 19075930
   PubMedGoogle Scholar
• Jaksch M, Múnera J, Bajpai R, Terskikh A, Oshima RG. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 2008; 68:7882 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-08-0723; PMID: 18829544
   PubMed Web of Science ®Google Scholar
• Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr., et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS One 2008; 3:e3655; http://dx.doi.org/10.1371/journal.pone.0003655; PMID: 18985161
   PubMed Web of Science ®Google Scholar
• Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009; 28:209 - 18; http://dx.doi.org/10.1038/onc.2008.374; PMID: 18836486
   PubMed Web of Science ®Google Scholar
• Kawamoto H, Yuasa T, Kubota Y, Seita M, Sasamoto H, Shahid JM, et al. Characteristics of CD133(+) human colon cancer SW620 cells. Cell Transplant 2010; 19:857 - 64; http://dx.doi.org/10.3727/096368910X508988; PMID: 20587144
   PubMed Web of Science ®Google Scholar
• Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008; 27:1749 - 58; http://dx.doi.org/10.1038/sj.onc.1210811; PMID: 17891174
   PubMed Web of Science ®Google Scholar
• Elsaba TM, Martinez-Pomares L, Robins AR, Crook S, Seth R, Jackson D, et al. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 2010; 5:e10714; http://dx.doi.org/10.1371/journal.pone.0010714; PMID: 20502714
   PubMed Web of Science ®Google Scholar
• Yu X, Lin Y, Yan X, Tian Q, Li L, Lin EH. CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?. Curr Colorectal Cancer Rep 2011; 7:253 - 9; http://dx.doi.org/10.1007/s11888-011-0106-1; PMID: 22131911
   PubMedGoogle Scholar
• Weinberg R, Fisher DE, Rich J. Dynamic and transient cancer stem cells nurture melanoma. Nat Med 2010; 16:758; http://dx.doi.org/10.1038/nm0710-758; PMID: 20613753
   PubMed Web of Science ®Google Scholar
• Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer 2012; 12:133 - 43; PMID: 22237392
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen J, Wang X, Yu L, Hu LH, Shen X. Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways. Acta Pharmacol Sin 2010; 31:944 - 52; http://dx.doi.org/10.1038/aps.2010.72; PMID: 20644552
   PubMed Web of Science ®Google Scholar
• Yi Y, Kamata-Sakurai M, Denda-Nagai K, Itoh T, Okada K, Ishii-Schrade K, et al. Mucin 21/epiglycanin modulates cell adhesion. J Biol Chem 2010; 285:21233 - 40; http://dx.doi.org/10.1074/jbc.M109.082875; PMID: 20388707
   PubMed Web of Science ®Google Scholar
• Zhu H, Miao ZH, Huang M, Feng JM, Zhang ZX, Lu JJ, et al. Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cells. Neoplasia 2009; 11:1226 - 34; PMID: 19881958
   PubMed Web of Science ®Google Scholar
• Feng JM, Zhu H, Zhang XW, Ding J, Miao ZH. Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity. Cancer Biol Ther 2008; 7:1726 - 31; http://dx.doi.org/10.4161/cbt.7.11.6728; PMID: 18787399
   PubMed Web of Science ®Google Scholar
• Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009; 347:70 - 8; http://dx.doi.org/10.1016/j.jim.2009.06.008; PMID: 19567251
   PubMed Web of Science ®Google Scholar